1. FDA label Desyrel (trazodone hydrochloride) tablets for oral use, approval 1981 [cited 2022 Dec 14]
2. FDA label Oleptro (trazodone) hydrochloride extended-release tablets initial approval 1981 [cited 2022 Dec 14]
3. Mendelson WB. A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry. 2005 Apr;66(4):469-76. doi: 10.4088/jcp.v66n0409. PMID: 15816789. [cited 2022 Dec 14]
4. Shin JJ, Saadabadi A. Trazodone. [Updated 2022 Jul 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470560/ [cited 2022 Dec 14]
5. James SP, Mendelson WB. The use of trazodone as a hypnotic: a critical review. J Clin Psychiatry. 2004 Jun;65(6):752-5. doi: 10.4088/jcp.v65n0605. PMID: 15291651. [cited 2022 Dec 14]
6. Haria M, Fitton A, McTavish D. Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders. Drugs Aging. 1994 Apr;4(4):331-55. doi: 10.2165/00002512-199404040-00006. PMID: 8019056. [cited 2022 Dec 14]
7. Fagiolini A, Comandini A, Catena Dell’Osso M, Kasper S. Rediscovering trazodone for the treatment of major depressive disorder. CNS Drugs. 2012 Dec;26(12):1033-49. doi: 10.1007/s40263-012-0010-5. Erratum in: CNS Drugs. 2013 Aug;27(8):677. PMID: 23192413; PMCID: PMC3693429. [cited 2022 Dec 14]
8. Sharma KD, Colangelo T, Mills A. Trazodone-induced parkinsonism: A case report. Int J Clin Pharmacol Ther. 2022 Apr;60(4):184-187. doi: 10.5414/CP204068. PMID: 35102822. [cited 2022 Dec 14]
9. Sarwar AI. Trazodone and Parkinsonism: The Link Strengthens. Clin Neuropharmacol. 2018 May/Jun;41(3):106-108. doi: 10.1097/WNF.0000000000000278. PMID: 29634584. [cited 2022 Dec 14]
10. Darko W, Guharoy R, Rose F, Lehman D, Pappas V. Myoclonus secondary to the concurrent use of trazodone and fluoxetine. Vet Hum Toxicol. 2001 Aug;43(4):214-5. PMID: 11474735. [cited 2022 Dec 14]
11. Finfgeld DL. Serotonin syndrome and the use of SSRIs. J Psychosoc Nurs Ment Health Serv. 2004 Feb;42(2):16-20. doi: 10.3928/02793695-20040201-04. PMID: 14982105. [cited 2022 Dec 14]
12. Looper KJ. Potential medical and surgical complications of serotonergic antidepressant medications. Psychosomatics. 2007 Jan-Feb;48(1):1-9. doi: 10.1176/appi.psy.48.1.1. PMID: 17209143. [cited 2022 Dec 14]
13. Jarema M, Dudek D, Landowski J, Heitzman J, Rabe-Jabłońska J, Rybakowski J. Trazodon–lek przeciwdepresyjny: mechanizm działania i miejsce w leczeniu depresji [Trazodon–the antidepressant: mechanism of action and its position in the treatment of depression]. Psychiatr Pol. 2011 Jul-Aug;45(4):611-25. Polish. PMID: 22232986. [cited 2022 Dec 14]
14. Khouzam HR. A review of trazodone use in psychiatric and medical conditions. Postgrad Med. 2017 Jan;129(1):140-148. doi: 10.1080/00325481.2017.1249265. Epub 2016 Oct 28. PMID: 27744763. [cited 2022 Dec 14]
15. Bossini L, Coluccia A, Casolaro I, Benbow J, Amodeo G, De Giorgi R, Fagiolini A. Off-Label Trazodone Prescription: Evidence, Benefits and Risks. Curr Pharm Des. 2015;21(23):3343-51. doi: 10.2174/1381612821666150619092236. PMID: 26088119. [cited 2022 Dec 14]
16. Yi XY, Ni SF, Ghadami MR, Meng HQ, Chen MY, Kuang L, Zhang YQ, Zhang L, Zhou XY. Trazodone for the treatment of insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Med. 2018 May;45:25-32. doi: 10.1016/j.sleep.2018.01.010. Epub 2018 Feb 7. PMID: 29680424. [cited 2022 Dec 14]
17. Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017 Feb 15;13(2):307-349. doi: 10.5664/jcsm.6470. PMID: 27998379; PMCID: PMC5263087. [cited 2022 Dec 14]
18. Kalgutkar AS, Henne KR, Lame ME, Vaz AD, Collin C, Soglia JR, Zhao SX, Hop CE. Metabolic activation of the nontricyclic antidepressant trazodone to electrophilic quinone-imine and epoxide intermediates in human liver microsomes and recombinant P4503A4. Chem Biol Interact. 2005 Jun 30;155(1-2):10-20. doi: 10.1016/j.cbi.2005.03.036. Epub 2005 Apr 18. PMID: 15978881. [cited 2022 Dec 14]
19. Erickson A, Harbin K, MacPherson J, Rundle K, Overall KL. A review of pre-appointment medications to reduce fear and anxiety in dogs and cats at veterinary visits. Can Vet J. 2021 Sep;62(9):952-960. PMID: 34475580; PMCID: PMC8360309. [cited 2022 Dec 14]
20. Mittur A. Trazodone: properties and utility in multiple disorders. Expert Rev Clin Pharmacol. 2011 Mar;4(2):181-96. doi: 10.1586/ecp.10.138. PMID: 22115401. [cited 2022 Dec 14]
21. Kast RE. Trazodone generates m-CPP: in 2008 risks from m-CPP might outweigh benefits of trazodone. World J Biol Psychiatry. 2009;10(4 Pt 2):682-5. doi: 10.1080/15622970902836022. PMID: 19384678. [cited 2022 Dec 14]
22. FDA Medication Guide Oleptro (trazodone hydrochloride) extended release tablets approval 1981 [cited 2022 Dec 14]
23. Maness D, Khan M, Nonpharmacologic Management of Chronic Insomnia published in the American Family Physician 2015;92(12):1058-1064 [cited 2022 Dec 14]
24. Apóstolo J, Bobrowicz-Campos E, Rodrigues M, Castro I, Cardoso D. The effectiveness of non-pharmacological interventions in older adults with depressive disorders: A systematic review. Int J Nurs Stud. 2016 Jun;58:59-70. doi: 10.1016/j.ijnurstu.2016.02.006. Epub 2016 Feb 17. PMID: 27087298. [cited 2022 Dec 14]
25. Schott G, Pachl H, Limbach U, Gundert-Remy U, Ludwig WD, Lieb K. The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials. Dtsch Arztebl Int. 2010 Apr;107(16):279-85. doi: 10.3238/arztebl.2010.0279. Epub 2010 Apr 23. PMID: 20467553; PMCID: PMC2868984. [cited 2022 Dec 14]
26. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci. 2000 Dec 15;20(24):9104-10. doi: 10.1523/JNEUROSCI.20-24-09104.2000. PMID: 11124987; PMCID: PMC6773038. [cited 2022 Dec 14]
27. Kuśmider M, Faron-Górecka A, Dziedzicka-Wasylewska M. Delayed effects of antidepressant drugs in rats. Behav Pharmacol. 2006 Dec;17(8):641-9. doi: 10.1097/FBP.0b013e3280116ea2. PMID: 17110791. [cited 2022 Dec 14]
28. Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA. The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry. 2022 Jul 20. doi: 10.1038/s41380-022-01661-0. Epub ahead of print. PMID: 35854107. [cited 2022 Dec 14]
29. Bossini L, Casolaro I, Koukouna D, Cecchini F, Fagiolini A. Off-label uses of trazodone: a review. Expert Opin Pharmacother. 2012 Aug;13(12):1707-17. doi: 10.1517/14656566.2012.699523. Epub 2012 Jun 20. PMID: 22712761. [cited 2022 Dec 14]
30. Jaffer KY, Chang T, Vanle B, Dang J, Steiner AJ, Loera N, Abdelmesseh M, Danovitch I, Ishak WW. Trazodone for Insomnia: A Systematic Review. Innov Clin Neurosci. 2017 Aug 1;14(7-8):24-34. PMID: 29552421; PMCID: PMC5842888. [cited 2022 Dec 14]
31. Martinon-Torres G, Fioravanti M, Grimley EJ. Trazodone for agitation in dementia. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004990. doi: 10.1002/14651858.CD004990. PMID: 15495135. [cited 2022 Dec 14]
32. Stein MD, Kurth ME, Sharkey KM, Anderson BJ, Corso RP, Millman RP. Trazodone for sleep disturbance during methadone maintenance: a double-blind, placebo-controlled trial. Drug Alcohol Depend. 2012 Jan 1;120(1-3):65-73. doi: 10.1016/j.drugalcdep.2011.06.026. Epub 2011 Jul 27. PMID: 21798674; PMCID: PMC3214692. [cited 2022 Dec 14]
33. Consumer Reports Should You Take Trazodone for Insomnia? published online April 4 2021 [cited 2024 April 22]